These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7880209)

  • 1. Use of pentoxifylline in the treatment of cerebral malaria.
    Landau Z; Attali M
    Clin Infect Dis; 1993 Jul; 17(1):137. PubMed ID: 7880209
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children.
    Di Perri G; Di Perri IG; Monteiro GB; Bonora S; Hennig C; Cassatella M; Micciolo R; Vento S; Dusi S; Bassetti D
    J Infect Dis; 1995 May; 171(5):1317-22. PubMed ID: 7751709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of pentoxifylline in the treatment of cerebral malaria.
    Moling O; Mian P
    Clin Infect Dis; 1994 Sep; 19(3):558-9. PubMed ID: 7880266
    [No Abstract]   [Full Text] [Related]  

  • 4. Pentoxifylline adjunct improves prognosis of human cerebral malaria in adults.
    Das BK; Mishra S; Padhi PK; Manish R; Tripathy R; Sahoo PK; Ravindran B
    Trop Med Int Health; 2003 Aug; 8(8):680-4. PubMed ID: 12869088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy in cerebral malaria.
    Mohanty S; Patel DK; Pati SS; Mishra SK
    Indian J Med Res; 2006 Sep; 124(3):245-60. PubMed ID: 17085828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline in cerebral malaria.
    Graninger W; Thalhammer F; Locker G
    J Infect Dis; 1991 Oct; 164(4):829. PubMed ID: 1894953
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of the quality of randomized clinical trials of adjunctive therapy for the treatment of cerebral malaria.
    Enwere G
    Trop Med Int Health; 2005 Nov; 10(11):1171-5. PubMed ID: 16262742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumour necrosis factor (TNF) production by antimalarial drugs used in cerebral malaria.
    Kwiatkowski D; Bate C
    Trans R Soc Trop Med Hyg; 1995; 89(2):215-6. PubMed ID: 7778153
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentoxifylline prevents murine cerebral malaria.
    Kremsner PG; Grundmann H; Neifer S; Sliwa K; Sahlmüller G; Hegenscheid B; Bienzle U
    J Infect Dis; 1991 Sep; 164(3):605-8. PubMed ID: 1869848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF-alpha therapy for chronic inflammation: reconsidering pentoxifylline as an alternative to therapeutic protein drugs.
    Whitehouse MW
    Inflammopharmacology; 2004; 12(3):223-7. PubMed ID: 15527546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report].
    Diallo BD; Diot B; Flament T; Plantier L; Diot P; Sow OY; Marchand-Adam S
    Rev Pneumol Clin; 2018 Feb; 74(1):48-51. PubMed ID: 29122398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tumor necrosis factor production by antimalarial drugs used in cerebral malaria.
    Wetsteyn JC
    Trans R Soc Trop Med Hyg; 1995; 89(6):700. PubMed ID: 8594703
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxpentifylline, tumour necrosis factor-alpha and Crohn's disease.
    MacDonald TT
    Gut; 1997 Apr; 40(4):559. PubMed ID: 9176092
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
    Dawlah ZM; Cabrera A; Ahern K; Levis WR
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041
    [No Abstract]   [Full Text] [Related]  

  • 15. Pentoxifylline and wellbeing in cancer.
    Tuckey JA; Parry BR; McCall JL
    Lancet; 1993 Sep; 342(8871):617. PubMed ID: 8102744
    [No Abstract]   [Full Text] [Related]  

  • 16. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
    Satapathy SK; Garg S; Chauhan R; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
    Am J Gastroenterol; 2004 Oct; 99(10):1946-52. PubMed ID: 15447754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of pentoxifylline in neonatal rats infected with group B streptococci.
    Mancuso G; Blandino G; Gambuzza M; Genovese F; Migliardo M; Carbone M; Fera MT; Cusumano V
    J Chemother; 1995 Oct; 7(5):417-9. PubMed ID: 8596123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentoxifylline acutely reduces protein catabolism in chronically uremic patients.
    Biolo G; Ciocchi B; Bosutti A; Situlin R; Toigo G; Guarnieri G
    Am J Kidney Dis; 2002 Dec; 40(6):1162-72. PubMed ID: 12460034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline (anti-tumor necrosis factor drug): effective adjuvant therapy in the control of ocular cicatricial pemphigoid.
    El Darouti MA; Fakhry Khattab MA; Hegazy RA; Hafez DA; Gawdat HI
    Eur J Ophthalmol; 2011; 21(5):529-37. PubMed ID: 21279976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria.
    Kremsner PG; Nüssler A; Neifer S; Chaves MF; Bienzle U; Senaldi G; Grau GE
    Immunology; 1993 Feb; 78(2):286-90. PubMed ID: 8473017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.